The importance of bladder wall thickness in the assessment of overactive bladder
Current Bladder Dysfunction Reports, 11/13/2009
|
Blatt AH et al. – The assessment of bladder wall thickness using ultrasound has been postulated to contribute diagnostic information in patients with voiding dysfunction. If proven as a diagnostic tool, this ... current gold standard. Unfortunately, enough discrepancy exists in the literature to prevent widespread application of this tool, and the role of bladder wall thickness assessment in the management of overactive bladder remains undetermined.
[more...]
|
Incidence analyses of bladder cancer in the Nile delta region of Egypt
Cancer Epidemiology, 10/20/2009
|
Fedewa SA et al. – Bladder cancer is the most common malignancy among Egyptian males and previously has been attributed to Schistosoma infection, a major risk factor for squamous cell carcinoma (SCC). Recently ... Future studies on sources and types of environmental pollution and exposures in relation to the spatial patterns of bladder cancer, particularly in Kotour District, may improve the understating of risk factors for bladder cancer in the region.
[more...]
|
192R Allele of Paraoxanase 1 (PON1) Gene as a New Marker for Susceptibility to Bladder Cancer
Anticancer Research, 11/10/2009
|
Ozturk O et al. – Arylesterase activity of PON1 would help the formation of free–radical type arylamine derivates on the bladder epithelial surface, so that secondary metabolites of paraoxon or related ... involved in formation of bladder carcinoma.
[more...]
|
Significant Association of XPD Codon 312 Single Nucleotide Polymorphism with Bladder Cancer Susceptibility in Taiwan
Anticancer Research, 11/10/2009
|
Chang C–H et al. – The heterozygous and homozygous A allele of the XPD codon 312 may be responsible for bladder carcinogenesis and useful in the early detection and prediction of bladder cancer.
[more...]
|
Sequence Variant on 3q28 and Urinary Bladder Cancer Risk: Findings from the Los Angeles-Shanghai Bladder Case-Control Study
Cancer Epidemiology, Biomarkers & Prevention, 10/27/2009
|
Stern MC et al. – The results suggest that a TP63 gene variant may increase susceptibility for the development of urinary bladder tumors with low risk of progression.
[more...]
|
Outcome of Simultaneous Transurethral Resection of Bladder Tumor and Transurethral Resection of the Prostate in Comparison with the Procedures in Two Separate Sittings in Patients with Bladder Tumor and Urodynamically Proven Bladder Outflow Obstruction
Journal of Endourology, 10/27/2009
|
Singh V et al. – TURBT and TURP can be ... of recurrence and progression of tumor, if performed in a properly selected group of patients.
[more...]
|
Efficacy of simplified bladder training in patients with overactive bladder receiving a solifenacin flexible-dose regimen: results from a randomized study
BJU International, 10/13/2009
|
Mattiasson A et al. – Combined treatment with solifenacin and simplified bladder training was more effective than solifenacin alone in ... frequency at weeks 8 and 16, and improving treatment satisfaction at week 16 in patients with OAB. Simplified bladder training did not improve on the benefits of solifenacin alone in the symptoms of urgency or incontinence.
[more...]
|
Heat-shock protein 70-2 (HSP70-2) expression in bladder urothelial carcinoma is associated with tumour progression and promotes migration and invasion
European Journal of Cancer, 11/19/2009
|
Garg M et al. – The data suggest that the HSP70–2 expression is associated with early spread and progression of urothelial carcinoma of bladder cancer and that HSP70 ... the potential therapeutic target for bladder urothelial carcinoma.
[more...]
|
The Boari bladder flap: an effective continent stoma for the high-compliance neurogenic bladder
BJU International, 11/24/2009
|
Baumgart E et al. – A BBF can be used to create a viable, functional stoma in the high–compliance neurogenic bladder, although the rate of stomal complications is high when the BBF is ... enterocystoplasty tissue.
[more...]
|
High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression
BMC Cancer, 11/13/2009
|
Egerod FL et al. – The results from this study support a potential involvement of Egr–1 in the progression from non–muscle invasive bladder cancers to muscle invasive bladder cancer.
[more...]
|
